fluconazole has been researched along with Pneumonia in 45 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Pneumonia: Infection of the lung often accompanied by inflammation.
Excerpt | Relevance | Reference |
---|---|---|
"The current recommended therapy for diffuse coccidioidal pneumonia involves initial treatment with amphotericin B deoxycholate or high-dose fluconazole, followed by an azole after clinical improvement." | 7.73 | Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole. ( Cheong, HJ; Kim, JH; Kim, MJ; Kim, WJ; Park, DW; Shin, C; Sohn, JW, 2006) |
"Twenty-two patients with AIDS and various forms of cryptococcosis were treated in an open-label study with 50 to 400 mg/day of fluconazole." | 7.67 | Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. ( Graybill, JR; Hartman, BJ; Murray, HW; Rowland, V; Sharkey, P; Squires, KE; Stern, JJ, 1988) |
"Aspergillus infection is the most frequent fungal infection associated with chronic granulomatous disease (CGD), and often results in a life-threatening situation." | 5.28 | [Effect of fluconazole on Aspergillus infection associated with chronic granulomatous disease]. ( Kawamori, J; Tsuruta, S; Yoshida, T, 1991) |
" The patient in this case responded to isavuconazole treatment for breakthrough infection due to B raffinosifermentans that was cultured from pleural fluid while on posaconazole prophylaxis post-bilateral lung transplantation for cystic fibrosis." | 5.12 | Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature. ( Al-Obaidi, M; Badali, H; Cañete-Gibas, C; Patterson, HP; Wiederhold, NP, 2021) |
" The onset of his hypoglycemia occurred within days after starting voriconazole and subsequently fluconazole for a fungal pneumonia." | 3.88 | Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report. ( Austin, E; Gunaratne, K; Wu, PE, 2018) |
" Fluconazole was continued until serum cryptococcal antigen (SCA) levels were negative in our patients as they had manifestations such as haemoptysis, cavitating or multi-lobar pneumonia and relatively high antigen levels, suggesting potentially serious disease." | 3.73 | Cavitating cryptococcal pneumonia in the immunocompetent host. ( Eng, P; Hsu, AA; Koh, MS; Kurup, A; Tan, BH, 2005) |
"The current recommended therapy for diffuse coccidioidal pneumonia involves initial treatment with amphotericin B deoxycholate or high-dose fluconazole, followed by an azole after clinical improvement." | 3.73 | Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole. ( Cheong, HJ; Kim, JH; Kim, MJ; Kim, WJ; Park, DW; Shin, C; Sohn, JW, 2006) |
" Coccidioidomycosis was suspected and empirically treated with fluconazole." | 3.72 | Coccidioidal pneumonia, arthritis, and soft-tissue infection after kidney transplantation. ( Blair, JE, 2004) |
" He received broad-spectrum antibiotics, fluconazole for oral candidiasis, and cotrimoxazole for possible Pneumocystis carinii." | 3.71 | Pneumonia due to Candida krusei. ( Costopoulos, H; Georgilis, K; Kontoyannis, D; Nanas, J; Petrocheilou-Paschou, V; Prifti, H; Stamatelopoulos, S, 2002) |
"Twenty-two patients with AIDS and various forms of cryptococcosis were treated in an open-label study with 50 to 400 mg/day of fluconazole." | 3.67 | Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients. ( Graybill, JR; Hartman, BJ; Murray, HW; Rowland, V; Sharkey, P; Squires, KE; Stern, JJ, 1988) |
"We present a case of a patient with hairy cell leukemia and pulmonary aspergillosis who developed a cycotic pulmonary artery aneurysm despite prolonged antifungal therapy." | 2.46 | Mycotic pulmonary artery aneurysm due to Aspergillus infection in a patient with leukemia: case report and review of the literature. ( Erasmus, J; Mattiuzzi, GN; Sever, M; Verstovsek, S, 2010) |
"Currently, cancer patients with microbial infection are a severe challenge in clinical treatment." | 1.72 | Synthesis of Hemiprotonic Phenanthroline-Phenanthroline ( Cui, Z; Fu, A; Fu, C; Keerthiga, R; Li, X; Tong, T; Yang, X; Zhang, Y; Zhao, Z, 2022) |
"Although "Candida pneumonia" is rarely being reported in critically ill patients, Candida airway colonization mainly by Candida albicans is common especially among patients with diabetes, malignancies, and kidney disorders." | 1.72 | Clinical impact of Candida respiratory tract colonization and acute lung infections in critically ill patients with COVID-19 pneumonia. ( Amiri, S; Erami, M; Fakhrehi, M; Getso, MI; Hashemi, SJ; Mehri, N; Momen-Heravi, M; Raiesi, O; Raissi, V; Yarahmadi, M, 2022) |
"Fungal pneumonia is considered as one of the most serious forms of pneumonia, the number of which has recently increased despite the use of new antimycotic drugs in pulmonology." | 1.48 | [CASE REPORT OF CANDIDA PNEUMONIA]. ( Beysenbekova, Z; Tayzhanova, D; Toleuova, A; Toyynbekova, R, 2018) |
"Bacterial pneumonia is a common cause of death worldwide." | 1.46 | Pulmonary delivery of tea tree oil-β-cyclodextrin inclusion complexes for the treatment of fungal and bacterial pneumonia. ( Du, L; Jin, Y; Li, M; Liu, B; Zhang, T; Zhu, L, 2017) |
"The relationship between pulmonary Cryptococcus infection and breast cancer is also discussed." | 1.36 | Asymptomatic pulmonary nodules in a patient with early-stage breast cancer: Cryptococcus infection. ( Cheng, YL; Hsu, GC; Hsu, HM; Hsu, KF; Ou, KW; Yu, JC, 2010) |
"After this treatment, pneumonia deteriorated." | 1.29 | [Treatment of severe pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA) and Candida krusei with granulocyte colony-stimulating factor (G-CSF): a case report]. ( Maezawa, H; Nakazawa, Y; Saito, A; Sakai, O; Sakamoto, M; Shiba, K; Shindou, N; Yoshida, M; Yoshikawa, K, 1993) |
"Case 2 was a boy with candida pneumonitis." | 1.29 | [Fluconazole therapy for pediatric patients with severe candidal infections]. ( Hisakawa, H; Kurashige, T; Misaki, Y; Morita, H; Okada, T; Sinohara, M; Tomoda, T; Wakiguchi, H; Watanabe, S, 1994) |
"Aspergillus infection is the most frequent fungal infection associated with chronic granulomatous disease (CGD), and often results in a life-threatening situation." | 1.28 | [Effect of fluconazole on Aspergillus infection associated with chronic granulomatous disease]. ( Kawamori, J; Tsuruta, S; Yoshida, T, 1991) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.22) | 18.7374 |
1990's | 11 (24.44) | 18.2507 |
2000's | 12 (26.67) | 29.6817 |
2010's | 16 (35.56) | 24.3611 |
2020's | 5 (11.11) | 2.80 |
Authors | Studies |
---|---|
Zhao, Z | 1 |
Li, X | 1 |
Cui, Z | 1 |
Tong, T | 1 |
Zhang, Y | 2 |
Yang, X | 1 |
Keerthiga, R | 1 |
Fu, C | 1 |
Fu, A | 1 |
Erami, M | 1 |
Raiesi, O | 1 |
Momen-Heravi, M | 1 |
Getso, MI | 1 |
Fakhrehi, M | 1 |
Mehri, N | 1 |
Yarahmadi, M | 1 |
Amiri, S | 1 |
Raissi, V | 1 |
Hashemi, SJ | 1 |
Oladele, RO | 1 |
Ettu, AO | 1 |
Medugu, N | 1 |
Habib, A | 1 |
Egbagbe, E | 1 |
Osinaike, T | 1 |
Makanjuola, OB | 1 |
Ogunbosi, B | 1 |
Irowa, OO | 1 |
Ejembi, J | 1 |
Uwaezuoke, NS | 1 |
Adeleke, G | 1 |
Mutiu, B | 1 |
Ogunsola, F | 1 |
Rotimi, V | 1 |
Allano, M | 1 |
Grimes, C | 1 |
Boivin, R | 1 |
Smith, G | 1 |
Dumaresq, J | 1 |
Leclere, M | 1 |
Oltean, HN | 1 |
Springer, M | 1 |
Bowers, JR | 1 |
Barnes, R | 1 |
Reid, G | 1 |
Valentine, M | 1 |
Engelthaler, DM | 1 |
Toda, M | 1 |
McCotter, OZ | 1 |
Al-Obaidi, M | 1 |
Badali, H | 1 |
Cañete-Gibas, C | 1 |
Patterson, HP | 1 |
Wiederhold, NP | 1 |
Wheeler, DJ | 1 |
Cascino, T | 1 |
Sharpe, BA | 1 |
Connor, DM | 1 |
Li, M | 1 |
Zhu, L | 1 |
Zhang, T | 1 |
Liu, B | 1 |
Du, L | 1 |
Jin, Y | 1 |
Toleuova, A | 1 |
Tayzhanova, D | 1 |
Toyynbekova, R | 1 |
Beysenbekova, Z | 1 |
Gunaratne, K | 1 |
Austin, E | 1 |
Wu, PE | 1 |
Viriyakosol, S | 1 |
Kapoor, M | 1 |
Okamoto, S | 1 |
Covel, J | 1 |
Soltow, QA | 1 |
Trzoss, M | 1 |
Shaw, KJ | 1 |
Fierer, J | 1 |
Beatty, NL | 1 |
Hanzlik, TP | 1 |
Connick, E | 1 |
Asadi Gharabaghi, M | 1 |
Allameh, SF | 1 |
Cicora, F | 1 |
Petroni, J | 1 |
Formosa, P | 1 |
Roberti, J | 1 |
Mohamed, AM | 1 |
Waheed, SA | 1 |
Mohamed, NM | 1 |
Clark, NM | 1 |
Sharma, V | 1 |
De, A | 1 |
Ahuja, A | 1 |
Lamoria, S | 1 |
Lamba, BM | 1 |
Roan, JN | 1 |
Hsieh, HY | 1 |
Tsai, HW | 1 |
Wu, CJ | 1 |
Hsu, CH | 1 |
Wu, SY | 1 |
Yang, YJ | 1 |
Chang, TC | 1 |
Ou, KW | 1 |
Hsu, KF | 1 |
Cheng, YL | 1 |
Hsu, GC | 1 |
Hsu, HM | 1 |
Yu, JC | 1 |
Sever, M | 1 |
Verstovsek, S | 1 |
Erasmus, J | 1 |
Mattiuzzi, GN | 1 |
Gill, PK | 1 |
Gill, JS | 1 |
Aruch, DB | 1 |
Bhusal, Y | 1 |
Hamill, RJ | 1 |
Rankin, BT | 1 |
Jariwala, S | 1 |
Petrocheilou-Paschou, V | 1 |
Georgilis, K | 1 |
Kontoyannis, D | 1 |
Nanas, J | 1 |
Prifti, H | 1 |
Costopoulos, H | 1 |
Stamatelopoulos, S | 1 |
Shrestha, RK | 1 |
Stoller, JK | 1 |
Honari, G | 1 |
Procop, GW | 1 |
Gordon, SM | 1 |
Arend, SM | 1 |
Kuijper, EJ | 1 |
Allaart, CF | 1 |
Muller, WH | 1 |
Van Dissel, JT | 1 |
Blair, JE | 1 |
Wang, CY | 1 |
Jerng, JS | 1 |
Ko, JC | 1 |
Lin, MF | 1 |
Hsiao, CH | 1 |
Lee, LN | 1 |
Hsueh, PR | 1 |
Kuo, SH | 1 |
Mele, G | 1 |
Musci, M | 1 |
Musto, C | 1 |
D'Amato, L | 1 |
Traficante, A | 1 |
Di Renzo, N | 1 |
Koh, MS | 1 |
Tan, BH | 1 |
Kurup, A | 1 |
Hsu, AA | 1 |
Eng, P | 1 |
Park, DW | 1 |
Sohn, JW | 1 |
Cheong, HJ | 1 |
Kim, WJ | 1 |
Kim, MJ | 1 |
Kim, JH | 1 |
Shin, C | 1 |
Tascini, C | 1 |
Ferranti, S | 1 |
Leonildi, A | 1 |
Menichetti, F | 1 |
Yoshida, M | 1 |
Yoshikawa, K | 1 |
Maezawa, H | 1 |
Shindou, N | 1 |
Sakamoto, M | 1 |
Nakazawa, Y | 1 |
Shiba, K | 1 |
Saito, A | 1 |
Sakai, O | 1 |
Wakiguchi, H | 1 |
Hisakawa, H | 1 |
Sinohara, M | 1 |
Watanabe, S | 1 |
Okada, T | 1 |
Misaki, Y | 1 |
Tomoda, T | 1 |
Morita, H | 1 |
Kurashige, T | 1 |
Inoue, N | 1 |
Takemoto, Y | 1 |
Kanamaru, A | 1 |
Kakishita, E | 1 |
Nakayama, S | 1 |
Hara, H | 1 |
Tsutsui, T | 1 |
Murakami, R | 1 |
Yamaguchi, N | 1 |
Tago, H | 1 |
Weinroth, SE | 1 |
Tuazon, CU | 1 |
Meis, JF | 1 |
Donnelly, JP | 1 |
Hoogkamp-Korstanje, JA | 1 |
De Pauw, BE | 1 |
Vassallo, J | 1 |
Galizia, AC | 1 |
Cuschieri, P | 1 |
Mirels, LF | 1 |
Stevens, DA | 1 |
Weber, C | 1 |
Maas, R | 1 |
Steiner, P | 1 |
Kramer, J | 1 |
Bumann, D | 1 |
Zander, AR | 1 |
Bücheler, E | 1 |
Matsumoto, K | 1 |
Ueno, K | 1 |
Yoshimura, H | 1 |
Morii, M | 1 |
Takada, M | 1 |
Sawai, T | 1 |
Mitsutake, K | 1 |
Shibakawa, M | 1 |
Friese, G | 1 |
Discher, T | 1 |
Füssle, R | 1 |
Schmalreck, A | 1 |
Lohmeyer, J | 1 |
Sotoyama, K | 1 |
Kawamori, J | 1 |
Tsuruta, S | 1 |
Yoshida, T | 1 |
Quist, P | 1 |
Tauris, P | 1 |
Stern, JJ | 1 |
Hartman, BJ | 1 |
Sharkey, P | 1 |
Rowland, V | 1 |
Squires, KE | 1 |
Murray, HW | 1 |
Graybill, JR | 1 |
2 reviews available for fluconazole and Pneumonia
Article | Year |
---|---|
Pulmonary infection secondary to Blastobotrys raffinosifermentans in a cystic fibrosis patient: Review of the literature.
Topics: Adult; Amphotericin B; Antifungal Agents; Cystic Fibrosis; Female; Fluconazole; Genes, Fungal; Human | 2021 |
Mycotic pulmonary artery aneurysm due to Aspergillus infection in a patient with leukemia: case report and review of the literature.
Topics: Abscess; Acyclovir; Amphotericin B; Aneurysm, Infected; Anti-Bacterial Agents; Antifungal Agents; An | 2010 |
1 trial available for fluconazole and Pneumonia
Article | Year |
---|---|
[An evaluation of a therapy with antibacterial and antifungal agents infections with hematological disorders].
Topics: Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Cefoperazone; Child; Child, Prescho | 1993 |
42 other studies available for fluconazole and Pneumonia
Article | Year |
---|---|
Synthesis of Hemiprotonic Phenanthroline-Phenanthroline
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Apo | 2022 |
Clinical impact of Candida respiratory tract colonization and acute lung infections in critically ill patients with COVID-19 pneumonia.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Caspofu | 2022 |
Antibiotic Guidelines for Critically Ill Patients in Nigeria.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clavulanic Acid; Community-Acqu | 2023 |
Topics: Animals; Canada; Cryptococcosis; Cryptococcus gattii; Fluconazole; Horse Diseases; Horses; Male; Pne | 2019 |
Suspected Locally Acquired Coccidioidomycosis in Human, Spokane, Washington, USA.
Topics: Aged, 80 and over; Antifungal Agents; Coccidioides; Coccidioidomycosis; Cough; Diagnosis, Differenti | 2020 |
When the Script Doesn't Fit: An Exercise in Clinical Reasoning.
Topics: Adult; Antifungal Agents; Chest Pain; Coccidioidomycosis; Community-Acquired Infections; Diagnosis, | 2017 |
Pulmonary delivery of tea tree oil-β-cyclodextrin inclusion complexes for the treatment of fungal and bacterial pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Antifungal Agents | 2017 |
[CASE REPORT OF CANDIDA PNEUMONIA].
Topics: Adolescent; Antifungal Agents; Candida albicans; Candidiasis; Delayed Diagnosis; Fluconazole; Humans | 2018 |
Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report.
Topics: Antifungal Agents; Diabetes Mellitus, Type 2; Drug Interactions; Fluconazole; Gliclazide; Humans; Hy | 2018 |
APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental
Topics: Aminopyridines; Amphotericin B; Animals; Antifungal Agents; Coccidioides; Disease Models, Animal; Fe | 2019 |
West African Man with a Cavitary Pneumonia and Cutaneous Nodule.
Topics: Adult; Antibodies, Fungal; Arizona; Biopsy; Coccidioides; Coccidioidomycosis; Fluconazole; Humans; I | 2019 |
Primary pulmonary cryptococcosis.
Topics: Adult; Antifungal Agents; Cryptococcosis; Female; Fluconazole; Humans; Pneumonia; Postpartum Period | 2014 |
A rare case of Cryptococcus gattii pneumonia in a renal transplant patient.
Topics: Adult; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Fluconazole; Humans; Kidney Transplan | 2015 |
An 87-Year-Old Man with Acute Catastrophic Pneumonia.
Topics: Acute Disease; Aged, 80 and over; Anti-Bacterial Agents; Antifungal Agents; Burkholderia cepacia; Ca | 2016 |
Acute Esophageal Necrosis Caused by Candidiasis in a Patient with Systemic Lupus Erythematosus.
Topics: Adult; Anti-Bacterial Agents; Candidiasis; Endoscopy, Digestive System; Esophagus; Female; Fluconazo | 2016 |
Pulmonary nodules caused by Schizophyllum commune after cardiac transplantation.
Topics: Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Female; Fluconazole; Heart Transplantation; H | 2009 |
Asymptomatic pulmonary nodules in a patient with early-stage breast cancer: Cryptococcus infection.
Topics: Antifungal Agents; Antigens, Fungal; Breast Neoplasms; Carcinoma, Ductal, Breast; Cryptococcosis; Cr | 2010 |
Blastoschizomyces capitatus pneumonia in an immuno-competent female.
Topics: Aged; Antifungal Agents; Diagnosis, Differential; Female; Fluconazole; Humans; Immunocompetence; Lun | 2011 |
Unusual cause of cellulitis in a patient with hepatitis C and cirrhosis.
Topics: Amphotericin B; Antibodies, Fungal; Antifungal Agents; Cellulitis; Cryptococcosis; Cryptococcus neof | 2011 |
Graded challenge protocol for fluconazole hypersensitivity in a patient with cryptococcal pneumonitis.
Topics: Administration, Oral; Adult; Antifungal Agents; Cryptococcosis; Desensitization, Immunologic; Diphen | 2012 |
Pneumonia due to Candida krusei.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Candida; Candidiasis; Fatal | 2002 |
Pneumonia due to Cryptococcus neoformans in a patient receiving infliximab: possible zoonotic transmission from a pet cockatiel.
Topics: Aged; Animals; Animals, Domestic; Antibodies, Monoclonal; Antifungal Agents; Antirheumatic Agents; A | 2004 |
Cavitating pneumonia after treatment with infliximab and prednisone.
Topics: Antibodies, Monoclonal; Arthritis, Rheumatoid; Cryptococcosis; Female; Fluconazole; Follow-Up Studie | 2004 |
Coccidioidal pneumonia, arthritis, and soft-tissue infection after kidney transplantation.
Topics: Antifungal Agents; Arthritis, Infectious; Coccidioides; Coccidioidomycosis; Fluconazole; Humans; Kid | 2004 |
Disseminated coccidioidomycosis.
Topics: Aged; Antifungal Agents; Coccidioides; Coccidioidomycosis; Drug Resistance, Fungal; Fluconazole; Fun | 2005 |
Pneumonia caused by Trichosporon pullulans in an autologous peripheral blood stem cell transplant recipient: possible misidentification.
Topics: Aged; Cryptococcus; Diagnostic Errors; Fluconazole; Humans; Male; Peripheral Blood Stem Cell Transpl | 2005 |
Cavitating cryptococcal pneumonia in the immunocompetent host.
Topics: Adult; Antifungal Agents; Cryptococcosis; Fluconazole; Humans; Immunocompetence; Male; Middle Aged; | 2005 |
Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole.
Topics: Adult; Antifungal Agents; Caspofungin; Coccidioidomycosis; Drug Therapy, Combination; Echinocandins; | 2006 |
Breakthrough Fusarium sp probable pneumonia during fluconazole therapy in an AIDS patient with diabetes, candidemia, Pneumocystis carinii pneumonia and cytomegalovirus disseminated infection.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Cytomegalovirus Infections; D | 2006 |
[Treatment of severe pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA) and Candida krusei with granulocyte colony-stimulating factor (G-CSF): a case report].
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Fl | 1993 |
[Fluconazole therapy for pediatric patients with severe candidal infections].
Topics: Adolescent; Candidiasis; Child; Esophagitis; Female; Fluconazole; Humans; Lung Diseases, Fungal; Mal | 1994 |
Alopecia associated with fluconazole treatment.
Topics: Aged; Alopecia; Cryptococcosis; Female; Fluconazole; Humans; Pneumonia | 1993 |
Aspergillus fumigatus pneumonia in neutropenic patients during therapy with fluconazole for infection due to Candida species.
Topics: Adolescent; Adult; Aged; Aspergillosis; Aspergillus fumigatus; Candidiasis; Female; Fluconazole; Hum | 1993 |
Mixed pulmonary infection with Nocardia, Candida, methicillin-resistant Staphylococcus aureus, and group D Streptococcus species.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Clotrimazole; Drug Therapy, Combination | 1996 |
Update on treatment of coccidioidomycosis.
Topics: Amphotericin B; Antifungal Agents; Coccidioidomycosis; Fluconazole; Humans; Immunocompromised Host; | 1997 |
[Importance of digital thoracic radiography in the diagnosis of pulmonary infiltrates in patients with bone marrow transplantation during aplasia].
Topics: Adult; Anemia, Aplastic; Anti-Infective Agents; Antibiotic Prophylaxis; Antifungal Agents; Bone Marr | 1999 |
Fluconazole-induced convulsions at serum trough concentrations of approximately 80 microg/mL.
Topics: Aged; Antifungal Agents; Candidiasis; Drug Administration Schedule; Female; Fluconazole; Humans; Mal | 2000 |
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cr | 2001 |
[Countermeasure for infections with granulocytopenia].
Topics: Agranulocytosis; Aminoglycosides; Anti-Bacterial Agents; Candidiasis; Cephalosporins; Drug Therapy, | 1992 |
[Effect of fluconazole on Aspergillus infection associated with chronic granulomatous disease].
Topics: Aspergillosis; Aspergillus fumigatus; Child, Preschool; Fluconazole; Granulomatous Disease, Chronic; | 1991 |
Short-term curative treatment of Aspergillus fumigatus pneumonia with fluconazole.
Topics: Aged; Aspergillosis; Aspergillus fumigatus; Female; Fluconazole; Humans; Lung Diseases, Fungal; Pneu | 1990 |
Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Adult; Antifungal Agents; Anti | 1988 |